Skip to content

Use of auxiliary Triamcinolone acetonide in glaucoma surgery: a clinical trial

Application of subtenon Triamcinolone acetonide in primary Trabeculectomies in non-inflammatory Glaucomas: a randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-53f8nh
Enrollment
Unknown
Registered
2018-09-04
Start date
2017-10-03
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

Intervention group: glaucoma surgery (trabeculectomy) will be performed in 29 patients with clinically uncontrolled glaucoma, with the subtenon injection of 4mg of triamcinolone acetonide at the end o
Procedure/surgery

Sponsors

Universidade Federal de São Paulo
Lead Sponsor
Universidade Federal de São Paulo
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Both genders; diagnosis of clinically uncontrolled non-inflammatory glaucomas with indication of trabeculectomy.

Exclusion criteria

Exclusion criteria: Diagnosis of inflammatory glaucomas (neovascular and uveitic glaucoma); Diagnosis of glaucomas with associated clinically relevant cataracts, and indication of combined surgery; Previous intraocular surgery, except for uncomplicated phacoemulsification or laser surgery performed more than 6 months prior to glaucoma surgery.

Design outcomes

Primary

MeasureTime frame
Success rates of intraocular pressure control during the postoperative follow-up period of the glaucoma sugeries. Evaluated as intraocular pressure measurements at 6, 12, 18 and 24 months postop, considering reference values: <18mmHg (criterion 1) and 15 mmHg (criterion 2). Analysis performed with survival analysis and log-rank test.

Secondary

MeasureTime frame
Outcome 1: differences in intraocular pressure values between groups in the postoperative period.Analysis performed with independent t test.;Outcome 2: differences in the number of hypotensive eyedrops (measured as number of medications in use) between groups in the postoperative period. Analysis performed with independent t test.;Outcome 3: differences in the number of postoperative surgical complications (measured as frequency of each complication) between groups. Analysis performed with independent t test.;Outcome 4: differences in the need for reoperation rates (measured as frequency of need for reoperation) between groups in the postoperative period. Analysis performed with independent t test.

Countries

Brazil

Contacts

Public ContactDiego Dias

Universidade Federal de São Paulo

diego.torres@outlook.com.br+55 11 982354795

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 12, 2026